Molecular biology of human papillomavirus infection and cervical cancer
The DOI matches its Crossref record; 172 of the 179 references it cites were found in a registry or an index.
Abstract
HPVs (human papillomaviruses) infect epithelial cells and cause a variety of lesions ranging from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types have been identified so far, with a subset of these being classified as high risk. High-risk HPV DNA is found in almost all cervical cancers (>99.7%), with HPV16 being the most prevalent type in both low-grade disease and cervical neoplasia. Productive infection by high-risk HPV types is manifest as cervical flat warts or condyloma that shed infectious virions from their surface. Viral genomes are maintained as episomes in the basal layer, with viral gene expression being tightly controlled as the infected cells move towards the epithelial surface. The pattern of viral gene expression in low-grade cervical lesions resembles that seen in productive warts caused by other HPV types. High-grade neoplasia represents an abortive infection in which viral gene expression becomes deregulated, and the normal life cycle of the virus cannot be completed. Most cervical cancers arise within the cervical transformation zone at the squamous/columnar junction, and it has been suggested that this is a site where productive infection may be inefficiently supported. The high-risk E6 and E7 proteins drive cell proliferation through their association with PDZ domain proteins and Rb (retinoblastoma), and contribute to neoplastic progression, whereas E6-mediated p53 degradation prevents the normal repair of chance mutations in the cellular genome. Cancers usually arise in individuals who fail to resolve their infection and who retain oncogene expression for years or decades. In most individuals, immune regression eventually leads to clearance of the virus, or to its maintenance in a latent or asymptomatic state in the basal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“human papillomavirus (HPV) is thought to initiate cervical carcinoma and squamous cell carcinoma of the head and neck in part by inactivating RB through expression of the E7 oncoprotein21,22”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
In the citing paper
“in HPV-induced cervical cancers, the virus initiates cancer in dividing cells in the basal layer of the epithelium, preventing their normal cell cycle exit and maturation21.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Barrier Function of the Skin: “La Raison d'Être” of the Epidermis
Madison, K. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12359.x · Cited by 1,188
Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Münger, K., Phelps, W. C., Bubb, V, Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,030
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 974
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Research works printed but not linked: 2
- Villiers de, 2001, Taxonomic classification of papillomaviruses, Papillomavirus Rep., 12, 57
- Sorathia, 2004, The E4 protein of HPV16 Interacts with E2 and regulates the trans-activation and replication functions of E2, 318
Cited by
Items 501–600 of 1,000
Torres‐Pineda, D. B., Mora‐García, M. D. L., García‐Rocha, R., Hernández‐Montes, J., Weiss‐Steider, B., Montesinos, J. J., Don‐López, C. A., Marín‐Aquino, L. A., Muñóz-Godínez, R., Ávila-Ibarra, L. R., et al. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155082 · Cited by 13
K-Mer Analyses Reveal Different Evolutionary Histories of Alpha, Beta, and Gamma Papillomaviruses
Chen, Z., Utro, F., Platt, D. E., DeSalle, R., Parida, L., Chan, P. K. S., & Burk, R. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179657 · Cited by 13
“After establishing infection by accessing the epithelial basal layer, PV genes are regulated by multiple promoters and a complex patterns of mRNA splicing that coordinates viral gene expression with different stages of the viral life cycle [5].”
BackgroundDendritic cell therapy in advanced gastric cancer: A promising new hope?
Tewari, M., Sahai, S., Mishra, R. R., Shukla, S. K., & Shukla, H. S. (2012) · Surgical Oncology · doi:10.1016/j.suronc.2012.03.003 · Cited by 13
“HPV vaccine (FDA approved; this protects against infection by HPV- types 16 and 18; that cause approximately 70 percent of all cases of cervical cancer worldwide) [4], and”
BackgroundPolansky, H., Itzkovitz, E., & Javaherian, A. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s123340 · Cited by 13
“More than 120 different subtypes of the virus have been identified, with ~40 different subtypes capable of infecting the anogenital tract.(1,2) Approximately 15 subtypes of HPV were shown to cause cervical cancer and cancers of the anus, vagina, vulva, penis, and oropharynx.”
The papillomavirus E2 DNA binding domain
Gay, G. D. P. (2008) · Frontiers in bioscience · doi:10.2741/3132 · Cited by 13
Ssedyabane, F., Niyonzima, N., Najjuma, J. N., Birungi, A., Atwine, R., Tusubira, D., Randall, T. C., Castro, C. M., Lee, H., & Ngonzi, J. N. J. (2024) · SAGE Open Medicine · doi:10.1177/20503121241252265 · Cited by 14
Human Oncogenic Viruses and Cancer
Ahuja, R., Jamal, A., Nosrati, N., Pandey, V., Rajput, P., Saxena, N., Sidhu, K., & Kumar, V. (2014) · doi:10.18520/cs/v107/i5/768-785 · Cited by 12
Presence of HPV 16 and HPV 18 in Spermatozoa and Embryos of Mice
Mastora, E., Kitsou, C., Evangelou, T., Zikopoulos, A., Ζαγοριανάκου, Ν., & Georgiou, I. A. (2021) · In Vivo · doi:10.21873/invivo.12615 · Cited by 12
Impact of HPV strains on molecular mechanisms of cervix cancer
Sharma, S., Chauhan, D., Kumar, S., & Kumar, R. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106465 · Cited by 14
Fernandes, Q., Sher, G., Prabhu, K. S., Kuttikrishnan, S., Merhi, M., Dermime, S., Junejo, K., Bhat, A. A., & Shahab Uddin, M. S. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436180.1 · Cited by 12
McKee, C. H., Onder, Z., Ashok, A., Cardoso, R. F., & Moroianu, J. (2013) · Virology · doi:10.1016/j.virol.2013.04.031 · Cited by 12
“The most common low risk HPV types, 6 and 11, cause benign anogenital warts, or condyloma accuminata, affecting 1–2% of young adults in many countries (Doorbar, 2006; zur Hausen, 2000, 2009).”
Carbone, A., & Paoli, P. D. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200717 · Cited by 12
“29 HPV have circular, double-stranded DNA genomes typically containing 8 genes; the L1 gene encodes the principal capsidic protein, and its nucleotide sequence constitutes the basis for HPV classification into more than 120 ‘types’,(28) while the L2protein is a minor virion component.(30) 31 The different HPV types ar…”
BackgroundChinchai, T., Chansaenroj, J., Junyangdikul, P., Swangvaree, S. S., Karalak, A., Niruthisard, S., & Poovorawan, Y. (2011) · PubMed · Cited by 12
Tian, Q., & Zang, Y.-H. (2015) · PubMed · Cited by 12
HPV16 E6 regulates annexin 1 (ANXA1) protein expression in cervical carcinoma cell lines
Calmon, M. F., Sichero, L. C., Boccardo, E., Villa, L. L., & Rahal, P. (2016) · Virology · doi:10.1016/j.virol.2016.05.016 · Cited by 12
“E7 allows the small number of infected cells to expand, increasing the number of cells that subsequently go on to produce infectious virions (Doorbar, 2006).”
BackgroundFukui, S., Nagasaka, K., Iimura, N., Kanda, R., Ichinose, T., Sugihara, T., Hiraike, H., Nakagawa, S., Sasajima, Y., & Ayabe, T. (2019) · Virology Journal · doi:10.1186/s12985-019-1180-2 · Cited by 12
Tong, C. C. L., & Palmer, J. N. (2020) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0000000000000692 · Cited by 12
“The viral genome amplification typically occurs in the mid-epithelial layers, whereas viral assembly and release occurs close to the epithelial surface [20,21].”
BackgroundChan, P. K. S., Liu, S., Cheung, J. L. K., Cheung, T., Yeo, W., Chong, P. C.-S., & Man, S. (2011) · Journal of Medical Virology · doi:10.1002/jmv.21889 · Cited by 13
“In a transformed tumor cell, the E6 and E7 proteins are expressed constitutively, and are thought to be essential for maintaining the malignant phenotype [zur Hausen, 2002; Doorbar, 2006].”
BackgroundRosini, S., Zappacosta, R., Bonaventura, G. D., Caraceni, D., Pilla, D. M., Girolamo, G. D., Esposito, A., Orsini, T., Setta, S., Vizzino, M., et al. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000214 · Cited by 12
(2014) · InTech eBooks · doi:10.5772/57062 · Cited by 12
The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review
Setiawan, D., Oktora, M. P., Hutubessy, R. C. W., Riewpaiboon, A., & Postma, M. J. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1357472 · Cited by 12
“(hrHPV), in particular, HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68 are responsible for cervical cancer [5,6].”
Rojo-León, V., García, C., Valencia, C., Méndez, M.-A., Wood, C. D., & Covarrubias, L. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.05.024 · Cited by 12
HPV Testing and its Role in Cervical Cancer Screening
Clarke, M. A. (2023) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000793 · Cited by 11
“81 The multistage pathway of cervical carcinogenesis involves a series of necessary steps that are considered universal across different settings and populations: (1) infection with a carcinogenic HPV type; (2) persistence of a transforming HPV infection that leads to the development of precancer; and (3) progression…”
BackgroundViral vector-based therapeutic HPV vaccines
Ji, T., Liu, Y., Li, Y., Li, C., & Han, Y. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01470-5 · Cited by 12
“HPV has a circular double-stranded DNA genome approximately 8 kb in size, with early and late regions encoding early (E1, E2, E4, E5, E6, and E7) and late (L1 and L2) proteins, respectively [34].”
Nanoparticles Based Therapeutic Approaches in Oncogenic Viral Infections: A Review
Ahmed, N., Abusalah, M. A. H., & Abuarqoub, A. H. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s547270 · Cited by 12
“7 Tumorigenesis is stimulated by a limited number of multifunctional oncoproteins produced by these small oncogenic DNA viruses.”
Lung, M. S. Y., Mak, W., & Murray, V. (2011) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-011-0018-8 · Cited by 11
WDHD1 facilitates G1 checkpoint abrogation in HPV E7 expressing cells by modulating GCN5
Zhou, Y., Pei, F., Ji, M., Zhang, F., Sun, Y., Zhao, Q., Wang, X., Hong, Y., Tian, J., Wang, Y., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07287-1 · Cited by 11
Sadeghi, R. V., Parsania, M., Sadeghizadeh, M., & Haghighat, S. (2022) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-130762 · Cited by 11
“Carcinogenic HPV types (such as HPV16 and HPV18) target cervical epithelial cells and are responsible for almost all cases of cervical cancer (13).”
BackgroundInfluentialFöldvári, M., & Kumar, P. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.78 · Cited by 13
DNA nanotherapy for pre-neoplastic cervical lesions
Peng, W., Dunton, C. J., Holtz, D. O., Parva, M., Stampler, K. M., Forwood, M., Gogoi, R. P., Lace, M. J., Anderson, D. G., & Sawicki, J. A. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.10.018 · Cited by 11
“The early and late regions encode viral proteins (E1, E2, E8^E2, E4, E6, E7 and L1–L2), while the LCR, consisting of 850 base pairs between the L1 and E6 genes, contains binding sites for multiple transcription factors and other proteins that define enhancer and silencer sequences, as well as the early p97 promoter th…”
BackgroundNonno, F. D., Pisani, G., Visca, P., Signore, F., Grillo, L. R., Baiocchini, A., Garbuglia, A. R., Sepe, S., Piacentini, M., & Falasca, L. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.40 · Cited by 11
Karpathiou, G., Batistatou, A. K., Forest, F., Clémenson, A., & Péoc’h, M. (2016) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000124 · Cited by 11
Ehrig, F., Häfner, N., Driesch, C., Christiansen, I. K., Beer, K., Schmitz, M., Runnebaum, I. B., & Dürst, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010112 · Cited by 11
“Virus-DNA integration into the host genome is considered to be one of the key events in HPV-induced cervical carcinogenesis [1,2].”
BackgroundBrendle, S. A., Li, J. J., Cladel, N. M., Shearer, D. A., Budgeon, L. R., Balogh, K. K., Atkins, H., Fujishima, M. C., Lopez, P. G., Christensen, N. D., et al. (2021) · Viruses · doi:10.3390/v13091824 · Cited by 11
“within the terminally differentiating compartment of stratified squamous epithelia [30,31].”
BackgroundSelf-citationHe, Z., Chen, R., Hu, S., Zhang, Y., Liu, Y., Li, C., Lv, F., & Xiao, Z. (2022) · BMC Cancer · doi:10.1186/s12885-022-09826-4 · Cited by 11
Sarmadi, S., Izadi‐Mood, N., Pourlashkari, M., Yarandi, F., & Sanii, S. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2010-y · Cited by 11
“The L1 capsid protein of HPV which represents about 90% of total protein on the surface of the virus is typically evident during the reproductive phase of the infection of all HPVs, the highest frequency of humoral immune responses being noticed for the L1 capsid protein [16, 23, 24].”
BackgroundAlarcón‐Romero, L. D. C., Peña, A. V., Illades‐Aguiar, B., Flores‐Alfaro, E., López‐Bayghen, E., Leyva‐Vázquez, M. A., & Castañeda-Saucedo, E. (2013) · Journal of Cytology · doi:10.4103/0970-9371.126644 · Cited by 11
“[17] Yu et al .”
Activities of E7 promoters in the human papillomavirus type 16 genome during cell differentiation
HANSEN, C. N., Nielsen, L. N., & Norrild, B. (2010) · Virus Research · doi:10.1016/j.virusres.2010.02.009 · Cited by 11
HPV 16 Is Related to the Progression of Cervical Intraepithelial Neoplasia Grade 2: A Case Series
D’Ottaviano, M. G. L., Discacciati, M. G., Andreoli, M. A., Costa, M. C., Termini, L., Rabelo‐Santos, S. H., Villa, L. L., & Zeferino, L. C. (2013) · Obstetrics and Gynecology International · doi:10.1155/2013/328909 · Cited by 11
“Hindawi Publishing Corporation Obstetrics and Gynecology International Volume 2013, Article ID 328909, 5 pages http://dx.doi.org/10.1155/2013/328909”
InfluentialHPV Associated with Recurrent Respiratory Papillomatosis
Seedat, R. Y., Combrinck, C. E., & Burt, F. J. (2013) · Future Virology · doi:10.2217/fvl.13.31 · Cited by 11
“The viral capsid is disassembled within the endosome, followed by migration of the viral genome across the cytoplasm and into the nucleus with the assistance of the L2 minor capsid protein [6,38].”
BackgroundCi, X., Yu, Z., Tang, W., Tu, Q., Jiang, P., Xue, X., Saunders, N. A., Zhang, L., Zhu, X., & Zhao, K. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10492-4 · Cited by 11
“…China 3 University of Queensland Diamantina Institute, The University of Queensland, TRI, Woolloongabba, Queensland 4102, Australia 4 Royal Brisbane & Women’s Hospital Campus, University of Queensland Centre for Clinical Research, Herston, Brisbane, QLD 4029, Australia DNA synthesis (Doorbar 2006).”
BackgroundLai, C., CHAO, A., Chang, C., Huang, C.-S., Wang, L. C., Hsueh, S., Lin, C.-T., Wu, T.-I., Jao, M., & Chou, H. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811000720 · Cited by 11
HPV-associated cancers: It's not all about the cervix
Moscicki, A. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.08.014 · Cited by 11
“It is likely that this metaplastic tissue supports viral persistence which is essential for cancer development (Moscicki et al., 1999; Doorbar, 2006).”
BackgroundInfluentialActis, S., Cazzaniga, M., Bounous, V. E., D’Alonzo, M., Rosso, R., Accomasso, F., Minella, C., & Biglia, N. (2023) · Carcinogenesis · doi:10.1093/carcin/bgad071 · Cited by 11
The Sequencing Bead Array (SBA), a Next-Generation Digital Suspension Array
Akhras, M. S., Pettersson, E., Diamond, L., Unemo, M., Okamoto, J., Davis, R. W., & Pourmand, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076696 · Cited by 10
“A model 10-plex SBA assay was designed to genotype ten high-risk HPV genotypes (HPV-16, HPV-18, HPV-33, HPV-35, HPV-39, HPV-45, HPV-52, HPV-56, HPV-58, and HPV-59) commonly associated with cervical cancer progression [21].”
MethodOrlando, P. A., Brown, J. S., Gatenby, R. A., & Guliano, A. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit172 · Cited by 10
“The molecular basis for HPV-induced cancer has been identified [2].”
BackgroundMoreas, H., Tsiambas, E., Lazaris, A. C., Nonni, A., Karameris, A., Metaxas, G., Armatas, H. E., & Patsouris, E. (2014) · PubMed · Cited by 10
Glycogen synthase kinase 3β and cyclin D1 expression in cervical carcinogenesis
Park, H., Lee, M., Kim, D. W., Hong, S. Y., & Lee, H. (2016) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2016.59.6.470 · Cited by 11
“Many studies have proved that integration of high-risk HPV DNA into host cell genome results in increased expression of oncoproteins E6 and E7, which interact with tumor suppressor proteins: p53 and retinoblastoma protein (Rb), respectively [3-5].”
BackgroundRagonnaud, E., Pedersen, A. G., & Holst, P. J. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12522 · Cited by 11
Shi, C., Yang, Y., Zhang, L., Zhang, T., Yu, J., Qin, S., & Gao, Y. (2019) · Oncology Reports · doi:10.3892/or.2019.7097 · Cited by 10
Alternations in mitochondrial genome in carcinogenesis of HPV positive cervix
Warowicka, A., Wołuń-Cholewa, M., Kwaśniewska, A., & Goździcka‐Józefiak, A. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104530 · Cited by 10
Human Papillomavirus and Cervical Cancer
Sağnıç, S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98490 · Cited by 10
Mapping Evidence on Management of Cervical Cancer in Sub-Saharan Africa: Scoping Review
Zibako, P., Hlongwa, M., Tsikai, N., Manyame, S., & Ginindza, T. G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19159207 · Cited by 10
“Cervical cancer (CC) is caused by persistent infection with Human papillomavirus (HPV), whose genome proteins E6 and E7 inactivate tumor suppression genes pRb and p53 leading to cervical intraepithelial neoplasia (CIN) which will then develop into invasive CC [2].”
InfluentialPapel del virus del papiloma humano en el desarrollo del cáncer del cuello uterino.
Núñez-Troconis, J. (2023) · Investigación Clínica · doi:10.54817/ic.v64n2a09 · Cited by 13
Eberhard, J., Onder, Z., & Moroianu, J. (2013) · Virology · doi:10.1016/j.virol.2013.08.017 · Cited by 12
“Fifteen of the sexually transmitted genital HPVs can be classified as high risk, notably HPV16, HPV18, HPV31, HPV33 and HPV45, which may result in squamous intraepithelial lesions capable of progressing to invasive carcinomas (Doorbar, 2006; Munger et al., 2004; zur Hausen, 2000, 2009).”
BackgroundMuller, M., & Demeret, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092581 · Cited by 11
“The HPV life cycle is tightly linked to the differentiation program of the host keratinocytes (reviewed in [2]).”
BackgroundSeropositivity of HPV 16 E6 and E7 and the risk of oral cancer
Wong, G. R., Ha, K., Himratul-Aznita, W. H., Yang, Y., Mustafa, W. M. W., Yuen, K., Abraham, M., Tay, K., Karen‐Ng, L. P., Cheong, S. C., et al. (2013) · Oral Diseases · doi:10.1111/odi.12218 · Cited by 10
“The typical HPV genome consists of 8000 bp of nucleotides and encodes for 8 or 9 open reading frames (ORFs) (Doorbar, 2006).”
BackgroundHigher prevalence and gene amplification of HPV16 in oropharynx as compared to oral cavity
Shigeishi, H., Sugiyama, M., Ohta, K., Rahman, M. Z., & Takechi, M. (2016) · Journal of Applied Oral Science · doi:10.1590/1678-775720160009 · Cited by 10
Fluorescence microscopy of H&E stained cervical biopsies to assist the diagnosis and grading of CIN
Castellanos, M. R., Nehru, V. M., Pirog, E. C., & Optiz, L. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.03.021 · Cited by 10
Zappacosta, R., & Rosini, S. (2008) · Technology in Cancer Research & Treatment · doi:10.1177/153303460800700302 · Cited by 10
Luckau, S., Wehrs, T. P., Brandau, S., Horn, P. A., & Lindemann, M. (2016) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000137 · Cited by 10
ALTUN, Z., Yarkın, F., Vardar, M. A., & Uguz, A. H. (2011) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2009-16463 · Cited by 9
Conesa‐Zamora, P., Santaclara, V., Gadea-Niñoles, E., Ortiz-Reina, S., & Pérez‐Guillermo, M. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.11.012 · Cited by 9
Human Papillomavirus Type 18 E6 and E7 Genes Integrate into Human Hepatoma Derived Cell Line Hep G2
Ma, T., Su, Z., Chen, L., Liu, S., Zhu, N., Wen, L., Yuan, Y., Lv, L., Chen, X., Huang, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037964 · Cited by 9
“These high-risk E6 and E7 oncoproteins then lead to cell proliferation through their association with PDZ domain proteins and, through p53 degradation, prevent the normal repair of chance mutations in the cellular genome [12].”
Challenges of Human Papillomavirus Infection and Associated Diseases in Low-Resource Countries
Nweke, M. C., Okolo, C. A., Daous, Y. M., & Esan, O. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0565-ra · Cited by 11
Viruses Infecting the European Catfish (Silurus glanis)
Saleh, M., Sellyei, B., Kovács, G., & Székely, C. (2021) · Viruses · doi:10.3390/v13091865 · Cited by 9
“PVs do not cause cell lysis, and viral particles are only released after the epithelial cell has been sloughed from the epithelial surface and degraded [93].”
BackgroundHolubeková, V., Mendelová, A., Žúbor, P., Kapustová, I., Švecová, I., Kúdela, E., Burjanivová, T., Lasabová, Z., & Danko, J. (2014) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000000 · Cited by 9
“The E6 protein causes degradation of the tumor suppressor protein p53 [2], whereas E7 affects the retinoblastoma protein by releasing it from the E2F transcriptional factor and leading the unchecked cell to uncontrolled progression [3].”
BackgroundSun, Y., Li, X., Song, S., Wang, Y., & Gu, H. (2016) · Oncotarget · doi:10.18632/oncotarget.9249 · Cited by 9
“HPVs are small DNA virus which is exclusively intraepithelial pathogens and dependent on differentiation status of host cells [4, 5].”
BackgroundMolecular identification of papillomavirus in ducks
Williams, R., Tolf, C., & Waldenström, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-27373-6 · Cited by 9
Interpretation of P16 expression as a marker of HPV in colorectal cancer.
Hafez, F. S., Meckawy, G. R., Alorabi, M., & Shakweer, M. M. (2022) · PubMed · doi:10.14670/hh-18-439 · Cited by 9
“Doorbar J. (2006). Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. (Lond). 110, 525-541. Gami B., Kubba F. and Ziprin P. (2014). Human papilloma virus and squamous cell carcinoma of the anus. Clin. Med. Insights. Oncol. 8, 113-119. Gillison M.L., Koch W.M., Capone R.B., Spafford M.,…”
BackgroundInfluentialCáncer cérvicouterino y virus del papiloma humano
de Larrea, G. Z. L., Martín, F., Ferreyra, C. F. S., Ávila-Morales, J., Rivas, M. F. J. L., Lara, M. R., & Malagón, G. V. (2012) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262012000400014 · Cited by 33
Hall, J., Iype, R., Armenoult, L., Taylor, J., Miller, C. J., Davidson, S. E., de Sanjosé, S., Bosch, F. X., Stern, P. L., & West, C. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.11.030 · Cited by 9
Smetana, K., Dvořánková, B., Lacina, L., Čada, Z., & Vonka, V. (2008) · Oncology Reports · doi:10.3892/or.20.1.75 · Cited by 9
Retraction Note: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis
Gupta, S. M., & Mania‐Pramanik, J. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0545-6 · Cited by 10
Opportunities to advance cervical cancer prevention and care
Brooke, G., Wendel, S. O., Banerjee, A., & Wallace, N. A. (2024) · Tumour Virus Research · doi:10.1016/j.tvr.2024.200292 · Cited by 8
“Because HPV oncogenes remain ubiquitously expressed in nearly all CaCx [101,102], there are efforts to improve CaCx care by targeting the HPV oncogenes using CRISPR/Cas9 [103] or small molecule inhibitors [104].”
Piccioli, Z. D., McKee, C. H., Leszczynski, A., Onder, Z., Hannah, E. C., Mamoor, S., Crosby, L., & Moroianu, J. (2010) · Virology · doi:10.1016/j.virol.2010.07.045 · Cited by 8
“The low risk HPV types are associated with benign anogenital warts which can affect 1–2% of young adults in many countries (Doorbar, 2006; zur Hausen, 2000; zur Hausen, 2009).”
BackgroundDiode lasers for the treatment of genital warts
Alharbi, R., Clanner-Engelshofen, B. M., Hildebrand, J. A., Schinabeck-Kühne, N., Niculescu, L., French, L. E., Kaudewitz, P., & Reinholz, M. (2019) · European Journal of Dermatology · doi:10.1684/ejd.2019.3600 · Cited by 8
Oral Human Papillomavirus: a multisite infection
Criscuolo, M., Morelatto, R., Belardinelli, P., Mosmann, J., Cuffini, C., & de Blanc, S. A. L. (2020) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.23462 · Cited by 8
“This contact implies the previous existence of ulceration or micro-wounds on the epithelial surface that allows its entry (1-3).”
BackgroundAmici, C., Donà, M. G., Chirullo, B., Bonito, P. D., & Accardi, L. (2020) · Cancers · doi:10.3390/cancers12071803 · Cited by 8
“That early, HPV-induced pre-neoplastic lesions are localized in a limited area, which is an additional advantage for therapy, as it allows for local treatment [20].”
BackgroundSivakumar, N., Narwal, A., Kamboj, M., Devi, A., Kumar, S., & Bhardwaj, R. (2021) · Head and Neck Pathology · doi:10.1007/s12105-021-01309-5 · Cited by 8
“Also, it serves as a key therapeutic as well as a prognostic marker [36].”
BackgroundHigh Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines
Bowden, S. J., Ellis, L. B., Kyrgiou, M., Fiander, A., & Hibbitts, S. J. (2022) · Vaccines · doi:10.3390/vaccines10101754 · Cited by 8
“The lifetime chance of HPV infection is estimated to be 80% [5].”
BackgroundChaiwongkot, A., Wattanathavorn, W., Seki, M., Suzuki, Y., Buranapraditkun, S., Kitkumthorn, N., Sasivimolrattana, T., & Bhattarakosol, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052535 · Cited by 8
“It was reported that high-risk HPV types (HR-HPVs) were detected in approximately 99.7% of cervical cancer cases [2,3].”
BackgroundInfluentialPowell, N. G., & Evans, M. (2015) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2015.02.003 · Cited by 8
Kwaśniewski, W. M., Goździcka‐Józefiak, A., Kotarska, M., Polak, G., Barczyński, B., Broniarczyk, J. K., NOWAK, W., Wołuń-Cholewa, M., Kwaśniewska, A., & Kotarski, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2916 · Cited by 8
“Progression from normal tissue to invasive cervical cancer (ICC) occurs through a series of increasing grades of SILs; low-grade squamous intraepithelial lesions (L-SILs) and high-grade squamous intraepithelial lesions (H-SILs) (1).”
Chaiwongkot, A., Pientong, C., Ekalaksananan, T., Vinokurova, S., Kongyingyoes, B., Chumworathayi, B., Patarapadungkit, N., Siriaunkgul, S., & Doeberitz, M. V. K. (2013) · Journal of Virological Methods · doi:10.1016/j.jviromet.2013.02.011 · Cited by 8
Onder, Z., & Moroianu, J. (2013) · Virology · doi:10.1016/j.virol.2013.11.020 · Cited by 9
“Mucosal alpha-HPVs can be further classified as low risk types, such as HPV 6 and 11, that are often associated with genital warts (condylomata acuminata), or high risk types, such as HPV 16 and 18, that are detected in invasive cervical carcinomas (Doorbar, 2006; Munger et al., 2004; zur Hausen, 2000, 2009).”
BackgroundChan, P. K. S., Liu, S., Cheung, T. H., Yeo, W., Ngai, S. M., Cheung, J. L. K., Chong, P. C.-S., & Man, S. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00105-10 · Cited by 8
“In cleared infections with normal or low-grade cervical cytological or histological abnormalities, the viral capsid protein L1 is abundantly expressed in the upper, differentiated layer of epithelial cells (11).”
BackgroundMarkov cellular automata models for chronic disease progression
Hawkins, J., & Molinek, D. K. (2015) · International Journal of Biomathematics · doi:10.1142/s1793524515500850 · Cited by 8
“For example in the case of hepatitis C virus (HCV) we use liver cells [32], and to apply the model to the human papilloma virus (HPV), a point in the math model would represent a configuration of epithelial cells [5].”
MethodPankam, T., Kerr, S. J., Teeratakulpisan, N., Rodbamrung, P., Wongkanya, R., Keelawat, S., Ruangritchankul, K., Hongchookiat, P., Watanapokasin, R. Y., & Phanuphak, N. (2017) · Papillomavirus Research · doi:10.1016/j.pvr.2017.04.006 · Cited by 8
“lated might explain these findings [28].”
A Mathematical Model of Cell Cycle Dysregulation Due to Human Papillomavirus Infection
Miller, A., Münger, K., & Adler, F. R. (2017) · Bulletin of Mathematical Biology · doi:10.1007/s11538-017-0299-9 · Cited by 8
“Viral progeny are assembled and released as the cell is desquamated (Doorbar 2006).”
García, C., Hernández-García, D., Valencia, C., Rojo-León, V., Pérez-Estrada, J. R., Werner, M., & Covarrubias, L. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.73 · Cited by 8
Wang, C., Chang, S.-L., Chu, F., Cheng, C., & Cheng, S. (2019) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.11162 · Cited by 8
Huber, L., Birk, R., Rotter, N., Aderhold, C., Lammert, A., Jungbauer, F., & Kramer, B. (2020) · Anticancer Research · doi:10.21873/anticanres.14014 · Cited by 8
Blimp-1 is a prognostic indicator for progression of cervical intraepithelial neoplasia grade 2
Saito, M., Rajesh, A., Innes, C., van der Griend, R., Fitzgerald, P., Simcock, B. J., Sykes, P. H., & Hibma, M. H. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-03993-4 · Cited by 8
“The host immune system plays a key role during cervical carcinogenesis (Doorbar 2006).”
BackgroundGao, P.-F., Liu, Y., Zhang, L., Zhang, S., Li, H., Wu, Y., & Wu, L. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.12.055 · Cited by 8
Galvis, M. M., Jardim, J. D. F., Kaminagakura, E., Santos‐Silva, A. R., Fonseca, F. P., de Almeida, O. P., Lopes, M. A., Pinto, C., & Kowalski, L. P. (2018) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2018.01.003 · Cited by 10
Perdomo-Lara, S., Buenahora, M., Álvarez, E., Martínez, F. G., Rebolledo, M., Aristizábal, F., Colegial, C., Horta, A., Rojas, J. A. B., Díaz‐Báez, D., et al. (2019) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.23188 · Cited by 8
“HPV infection is considered a sexually transmitted disease, and some sexual practices as lifetime coital sex partnership numbers and the number of oral sex partners has been associated with HPV transmission to the oral mucosa (7-9) and may increase the risk of HPVoral infections and generate important changes in the o…”
BackgroundTinelli, A., Leo, G., Pisano, M., Storelli, F., Leo, S., Vergara, D., & Malvası, A. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109789978739 · Cited by 7
“When this regulation is disrupted and E6 and E7 are overexpressed, they can abrogate normal tumor-suppressive function and cell cycling, and this process is considered necessary for incurring a malignant phenotype [3].”
BackgroundBurd, E. M., & Dean, C. L. (2016) · ASM Press eBooks · doi:10.1128/9781555819040.ch8 · Cited by 7
HPV-assoziiertes Karzinom des weiblichen Genitaltrakts: Molekulare Mechanismen der Entstehung
Reuschenbach, M., Vinokurova, S., & Doeberitz, M. V. K. (2011) · Der Pathologe · doi:10.1007/s00292-011-1474-7 · Cited by 10
Metadata
- Authors
- Doorbar, J.
- Affiliations
- National Institute for Medical Research (GB)
- Corresponding author
- Doorbar, John
- ORCID
- Doorbar, John
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2006-04-11
- Volume
- 110
- Issue
- 5
- Pages
- 525-541
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2052489835
- Cited by
- 1,072
- References
- 179
- Citations by year
- 2026: 30 · 2025: 35 · 2024: 34 · 2023: 41 · 2022: 51 · 2021: 43 · 2020: 52 · 2019: 45 · 2018: 60 · 2017: 55 · 2016: 58 · 2015: 64 · 2014: 73 · 2013: 98 · 2012: 83
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human papillomavirus, cervical cancer, HPV16, high-risk HPV, viral gene expression, cervical neoplasia, cervical transformation zone, E6 oncoprotein, E7 oncoprotein, retinoblastoma protein, p53 degradation, PDZ domain proteins, abortive infection, viral latency, immune clearance
- MeSH terms
- Uterine Cervical Neoplasms, Female, Humans, Precancerous Conditions, Virus Latency, Disease Progression, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.